441 related articles for article (PubMed ID: 20620420)
1. The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective.
Mendis S
Prog Cardiovasc Dis; 2010; 53(1):10-4. PubMed ID: 20620420
[TBL] [Abstract][Full Text] [Related]
2. From Framingham to North Karelia: from descriptive epidemiology to public health action.
Puska P
Prog Cardiovasc Dis; 2010; 53(1):15-20. PubMed ID: 20620421
[TBL] [Abstract][Full Text] [Related]
3. Preface-Global impact of the Framingham Heart Study.
Wilson PW
Prog Cardiovasc Dis; 2010; 53(1):3. PubMed ID: 20620418
[No Abstract] [Full Text] [Related]
4. The global impact of the Framingham Heart Study: editor's introduction.
Greenberg H
Prog Cardiovasc Dis; 2010; 53(1):1-2. PubMed ID: 20620417
[No Abstract] [Full Text] [Related]
5. The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clock.
Kengne AP; Turnbull F; MacMahon S
Prog Cardiovasc Dis; 2010; 53(1):45-51. PubMed ID: 20620425
[TBL] [Abstract][Full Text] [Related]
6. From Framingham to the Framework Convention on Tobacco Control.
Yach D
Prog Cardiovasc Dis; 2010; 53(1):52-4. PubMed ID: 20620426
[No Abstract] [Full Text] [Related]
7. The Abu Dhabi Cardiovascular Program: the continuation of Framingham.
Hajat C; Harrison O
Prog Cardiovasc Dis; 2010; 53(1):28-38. PubMed ID: 20620423
[TBL] [Abstract][Full Text] [Related]
8. The Framingham Heart Study: impact on the prevention and control of cardiovascular diseases in India.
Reddy KS; Satija A
Prog Cardiovasc Dis; 2010; 53(1):21-7. PubMed ID: 20620422
[TBL] [Abstract][Full Text] [Related]
9. Interview of William Kannel, MD. Interview by Peter Wilson, Henry Greenberg.
Kannel W
Prog Cardiovasc Dis; 2010; 53(1):4-9. PubMed ID: 20620419
[No Abstract] [Full Text] [Related]
10. Deciphering the causes of cardiovascular and other complex diseases in populations: achievements, challenges, opportunities, and approaches.
Yusuf S; Anand S
Prog Cardiovasc Dis; 2010; 53(1):62-7. PubMed ID: 20620428
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure and cardiovascular disease: tracing the steps from Framingham.
Turnbull F; Kengne AP; MacMahon S
Prog Cardiovasc Dis; 2010; 53(1):39-44. PubMed ID: 20620424
[TBL] [Abstract][Full Text] [Related]
12. Framingham Heart Study: the first 20 years.
Oppenheimer GM
Prog Cardiovasc Dis; 2010; 53(1):55-61. PubMed ID: 20620427
[TBL] [Abstract][Full Text] [Related]
13. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
[TBL] [Abstract][Full Text] [Related]
14. Challenges for the management of hypertension in low-resource settings.
Mendis S
Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
[TBL] [Abstract][Full Text] [Related]
15. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.
Mosca L; Edelman D; Mochari H; Christian AH; Paultre F; Pollin I
J Womens Health (Larchmt); 2006; 15(1):24-34. PubMed ID: 16417415
[TBL] [Abstract][Full Text] [Related]
16. The Framingham Heart Study's impact on global risk assessment.
Bitton A; Gaziano TA
Prog Cardiovasc Dis; 2010; 53(1):68-78. PubMed ID: 20620429
[TBL] [Abstract][Full Text] [Related]
17. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
Wells S; Broad J; Jackson R
N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
[TBL] [Abstract][Full Text] [Related]
18. Global preventive policies. Strategies at European and worldwide level.
Kotseva K
Rev Esp Cardiol; 2008 Sep; 61(9):960-70. PubMed ID: 18775238
[TBL] [Abstract][Full Text] [Related]
19. The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Cardiovascular diseases.
Nishtar S; Faruqui AM; Mattu MA; Mohamud KB; Ahmed A
J Pak Med Assoc; 2004 Dec; 54(12 Suppl 3):S14-25. PubMed ID: 15745323
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
